Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert E. Landry currently holds 8,184 shares of REGENERON PHARMACEUTICALS INC (REGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert E. Landry has been a net seller of REGN stock. They have purchased $0 and sold $23.4M worth of shares.
Robert E. Landry's most recent insider trade was on Sep 15, 2026, when they sold 1,000 shares at $72.13 per share.
Robert E. Landry serves as Executive at REGENERON PHARMACEUTICALS INC (REGN). They have executed 456 insider transactions totaling $23.4M over their tenure at the company.
Robert E. Landry holds the position of Executive at REGENERON PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Robert E. Landry has shown a selling trading pattern, with $0 in total purchases and $23.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robert E. Landry was on Dec 12, 2023, when they sold $5.5M worth of REGN shares. This transaction involved 6,381 shares at $856.71 per share.
Robert E. Landry currently owns 8,184 shares of REGENERON PHARMACEUTICALS INC (REGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert E. Landry's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert E. Landry has 456 Form 4 filings on record as an insider at REGENERON PHARMACEUTICALS INC.
Set alerts for Robert E. Landry and 40,000+ other insiders.